+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line



Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line



Proceedings of the National Academy of Sciences of the United States of America 74(1): 272-275



Cells from the malignant teratocarcinoma line PCC4.azal were treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine. Fifty-five clones were isolated from the surviving cells. Twelve clones are unable to form tumors in the syngeneic 129/Sv mice. However, these "tum-" clones form tumors as readily as the original cells when they are injected into irradiated mice. Moreover, they stimulate the production of immune memory cells, which protect the injected animals and confer resistance by adoptive transfer. The tum- clones are therefore unable to generate tumors in syngeneic mice because they elicit an immune rejection response.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041216628

Download citation: RISBibTeXText

PMID: 264681

DOI: 10.2307/66558


Related references

Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice. Proceedings of the National Academy of Sciences of the United States of America 76(10): 5282-5285, 1979

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line. Proceedings of the National Academy of Sciences of the United States of America 75(3): 1519-1523, 1978

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 1. rejection by syngeneic mice. Journal of Experimental Medicine 152(5): 1175-1183, 1980

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. Journal of Experimental Medicine 152(5): 1175-1183, 1980

Isolation in newborn mice of tumour cell variants from a polyoma-transformed non-malignant cell line. European Journal of Cancer 8(1): 107-109, 1972

Interleukin 12 gene transfer to mouse renal cell carcinoma cell line results in tumor rejection in syngeneic hosts. Journal of Urology 157(4 Suppl. ): 107, 1997

Interleukin 2 gene transfer to mouse renal cell carcinoma cell line leads to tumor rejection in syngeneic host. Journal of Urology 155(5 Suppl. ): 652A, 1996

Aggregation-deficient variants of the H6 teratocarcinoma cell line. Progress in Clinical and Biological Research 97: 173-192, 1982

Immunogenic variants obtained by mutagenesis of mouse masto cytoma p 815 6. occasional escape from host rejection due to antigen loss secondary variants. International Journal of Cancer 31(1): 119-124, 1983

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. European Journal of Immunology 12(5): 406-412, 1982

Immunogenic tumor cell variants obtained by mutagenesis. Archives de Biologie 92(4): 517-519, 1981

The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis. Cellular Immunology 92(1): 123-133, 1985

Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration. Immunobiology 186(5): 339-350, 1992

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. European Journal of Immunology 12(5): 401-406, 1982

Cell fusion-impaired variants of a mouse lymphocytic cell line obtained by single-step selection for polyethylene glycol resistance. Somatic Cell Genetics 6(1): 127-137, 1980